The number of patients who require maintenance on anticoagulation therapy (warfarin/Coumadin ®) for minimizing risk of cardiovascular events like stroke or thromboembolism is increasing.

Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...

The anticoagulation management system should provide an appropriate level of staff training, ongoing educational development, and documented competency assessment for all multidisciplinary ...

DURHAM, NC, UNITED STATES, November 5, 2024 /EINPresswire / -- Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis ... availability of ...

Participation Reinforces Cadrenal's Commitment to Innovation, Education and Improved Patient Outcomes with Anticoagulation Therapy PONTE ... of anticoagulation management to ensure the best ...

Exclusion criteria were ibuprofen allergy, anticoagulant therapy, systemic disease ... and its Combinations in Specialty Care ...

A flying puck can cause serious damage to the brain and spine; Are neck guards the answer? Data from rugby provides a ...

The improved engagement with HF patients intended to optimize GDMT was very modest, but did lead to increased use of MRAs.

Updated guidelines on allogeneic hematopoietic stem cell transplantation for myelofibrosis examine spleen-related ...

Experts from NYU Langone Heart will present the latest advancements in cardiovascular science and clinical care at the 2024 American Heart Association's Scientific Sessions, held from November 16 to ...

Antithrombotic therapy is a key element of secondary prevention in patients ... This review provides an update on certain difficult scenarios in antithrombotic management, with a focus on recent ...

Pfizer's non-COVID product revenues surged 14% operationally last quarter. The oncology business delivered exceptional ...